Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Biomarker Research Grant: Diagnostic and Prognostic Biomarker Development for Myasthenia Gravis and Related Neuromuscular Junction Disorders

    Biomarker Research Grant: Diagnostic and Prognostic Biomarker Development for Myasthenia Gravis and Related Neuromuscular Junction Disorders funds researchers developing biomarkers to improve diagnosis and prognosis.

    Browse similar grants
    Foundation Grants for Biomedical ResearchCancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Pediatric MG Research Grant: Understanding and Treating Myasthenia Gravis in Pediatric and Adolescent Populations

    Pediatric MG Research Grant supports investigators studying myasthenia gravis in children and adolescents to improve diagnosis, treatment, long-term outcomes, and quality of life.

    MGFADue Nov 18, 2026· 3d$125,000

    Seronegative MG Pilot Grant: Diagnostic and Mechanistic Research for Seronegative Myasthenia Gravis

    Seronegative MG Pilot Grant supports researchers studying disease mechanisms and diagnostic approaches to distinguish seronegative myasthenia gravis from mimicking conditions and improve clinical management.

    MGFADue Nov 18, 2026· 3d$125,000

    Neuromuscular Research Grants

    Neuromuscular Research Grants support mid-career and established investigators pursuing innovative muscle and nerve disorder research to achieve breakthroughs or develop new research techniques and applications.

    ANFDue Dec 4, 2026· 19d$100,000

    2026 MGFA Registry & Real-World Data Research Funding Opportunity

    2026 MGFA Registry & Real-World Data Research Funding Opportunity supports investigators using patient-reported and clinical data to improve lives affected by myasthenia gravis and related disorders.

    MGFAForecasted Aug 15, 2027$10,000Forecasted

    IMNM Research Grant

    IMNM Research Grant supports researchers studying immune-mediated necrotizing myopathy to advance understanding of the disease, develop or improve treatments, and enhance patients' quality of life.

    TMAForecasted May 20, 2027$150,000Forecasted